Meet the Board of Directors
Jon Bayless, Ph.D.
Jon Bayless is a general partner with Sevin Rosen Funds, where he has been since 1981. A veteran networking investor who has taken a lead role in nurturing several early-stage companies, Bayless led the firm’s early investments in, and served as the chairman of, CIENA Corp. and Landmark Graphics Corp., both public companies. He currently focuses on investment opportunities created by the transition of telecommunications networks to Internet protocol, and wireless and business applications in the cloud.
Prior to Sevin Rosen, Baless was vice-president of engineering at Arthur A. Collins Inc., leading an R&D organization focused on developing advanced navigation, computer and telecommunications systems. He also worked for the Defense Information Services Agency and the Motorola Aerospace Center.
Bayless currently sits on the boards of portfolio companies Extenet, GENBAND, NetSocket, Vidyo, WaveBender, and Xtera Communications. He has helped secure exits for many of Sevin Rosen’s most prominent telecommunications-infrastructure companies, including Monterey Networks, Navarro Networks and Lightspeed.
Outside of Sevin Rosen, Bayless sits on the Board of Visitors for the Oklahoma University College of Engineering. He earned a B.S. in electrical engineering from the University of Oklahoma, a master’s degree in electrical engineering from the University of Alabama and a Ph.D. in the same subject from Arizona State University, where he was also a National Defense Education Act (NDEA) Fellow.
Lou Bock, M.B.A.
Lou Bock, a partner at Santé Ventures, is an industry veteran focused on identifying emerging biopharmaceutical, device and platform technology companies. Bock sits on the boards of Ascenta Therapeutics, diaDexus, Horizon Therapeutics, Orexigen Therapeutics, SGX Pharmaceuticals and Zogenix. As a former partner of Scale Venture Partners, he is responsible for that firm’s investments in Dynavax Technologies (NASDAQ: DVAX), Prestwick Pharmaceuticals, Seattle Genetics (NASDAQ: SGEN), and Somaxon (NASDAQ: SOMX).
Bock joined Scale Venture Partners in 1997 from Gilead Sciences, where he held positions in research, project management, business development, and sales. While at Gilead, Bock was the project manager for Gilead's approved antiviral drug, Vistide, and was responsible for the discovery of Gilead's novel thrombin aptamer. Previous to Gilead, he was a research associate at Genentech.
Bock holds an M.B.A. from California State University, San Francisco and a B.S. in biology from California State University, Chico. In 1992 Lou was published in Nature magazine. Bock et al. Nature 355, 564-566 (1992).
José Cárdenas, J.D.
José Cárdenas is Senior Vice President and General Counsel of Arizona State University. A 1977 Stanford University Law School graduate, he was a partner in the law firm of Lewis and Roca before joining ASU in 2009. He also served as the firm’s managing partner and later as its chairman. He has been recognized for his accomplishments as a lawyer including an “AV/Preeminent Attorney” rating with Martindale-Hubbell and listings in Southwest Super Lawyers and The Best Lawyers in America ®, and his induction in 2010 to the Maricopa County Bar Association Hall of Fame. He is a member of the American Law Institute and a Fellow of the American Bar Foundation.
Cárdenas serves as a University representative on and to the boards of directors of ASU affiliated and related entities including the Center for the Future of Arizona and Zócalo Public Square. He also serves on the boards of Southwest Gas Corporation, Xico Inc., (an ethnic arts organization), Swift Transportation, and the CALA Alliance, (which promotes Latino arts and culture). Cárdenas is a member of the executive committee of the Arizona Super Bowl Host Committee, (since 2003), and he is a Trustee of the Virginia G. Piper Charitable Trust. He is also a past chairman of the Translational Genomics Research Institute (TGen), O’Connor House, Greater Phoenix Leadership and the Valley of the Sun United Way boards of directors. He has also served on many other boards of directors including those of Chicanos Por La Causa, the Arizona Hispanic Chamber of Commerce and Los Abogados Hispanic Bar Association. Cárdenas also served as a commissioner on Arizona’s Commerce and Economic Development Commission and he served three Governors as president of the Arizona-Mexico Commission.
Since 2003, Cárdenas has served as the host of the Eight/KAET weekly public affairs program, Horizonte, which focuses on Arizona issues through a Hispanic lens. In 2000, he received the Mexican government's Ohtli award given to U.S. residents of Mexican descent in recognition of their service to Mexican communities in the United States. He was Valley Leadership’s 2000 Man of the Year.
Delia Chavarría, M.B.A.
Delia Chavarría is a Global Marketer at BioMarin Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of first-in-class and best-in-class therapeutics for patients living with serious and life-threatening rare genetic diseases. As part of BioMarin’s Commercial team, she has supported the establishment and management of marketing and distribution partnerships throughout Asia Pacific and Latin America.
Chavarría joined BioMarin from Booz Allen Hamilton, where she was a Management Consultant leading business development activities and client projects in the healthcare space. Before Booz Allen, Chavarría held different positions with increasing level of responsibility at Genentech and at the FDA’s Center for Devices and Radiological Health.
Chavarría holds an M.B.A. from the Haas School of Business at University of California, Berkeley and a B.S.E. in Chemical Engineering from Tulane University.
Augustine V. Cheng, J.D. (ex officio)
Augie Cheng assumed his post as AzTE’s managing director and chief legal officer in August 2007. Cheng came to AzTE from Columbia University, where he was chief counsel of the Patent & Licensing Group in the office of the general counsel. In that capacity, he was responsible for a team of several attorneys and all legal affairs relating to Columbia’s patent protection and licensing programs. Read full bio...
Tony Corey, M.B.A (Chair)
In October, 2002, Corey retired as President and CEO of Rodel, Inc. after five years with this up and coming semiconductor company. During his tenure, which included the two worst recessions in the history of the semiconductor industry, Rodel witnessed outstanding growth in sales and profits, propelling its valuation from $260 million to over $2 billion during his stewardship. Valued at more than $3 billion today, Rodel is the global leader in Chemical Mechanical Planerization materials (CMP) a key process to make semiconductor chips. Rodel’s technology touches almost every chip made in the world today. The company was fully acquired by Rohm and Haas in 2002.
Prior to joining Rodel, Corey held several positions of increasing responsibilities around the world with Rohm and Haas ($13 Billion). His assignments took him and his family for 10 years overseas in England, Germany, France, and Brazil. During his career, he worked in the textiles, leather, paper, plastics, and coatings industries. His last position at Rohm and Haas was Corporate Vice President and a member of the senior management leadership council.
Corey holds a B.S. in biology from the American University of Beirut, an M.S. in chemical engineering from Ohio State University, and an M.B.A. from Widener University. He is fluent in English, French, Arabic, Portuguese, and adequate in Spanish. Before entering the corporate world, Corey was a Senior Lecturer at Widener University for two years (chemical engineering and industrial management).
Since retirement from the corporate world, Corey has started and co-founded several ventures: Corey Capital (global equity investments), UrbanLogic (real estate development), Mt Cedar Properties (real estate management), and TradeCom (commodities trading). His community work has focused mainly on education and mentoring young entrepreneurs.
Patrick J. Mallon
Pat Mallon has extensive senior and C-level executive experience in the bio/pharmaceutical, medical device and life sciences industries with expertise in the conceptualization, development and commercialization of new, cutting-edge technologies, services, and products. He has a successful track record in building organizations in both start-up and Fortune 500 companies including founding five companies and one investment fund.
Mallon was integral in the development and commercialization of the Nobel Prize-winning PCR technology and introduction of the world’s first protease inhibitor for HIV disease. Also, he has been responsible for product sales ranging from inception to over $1 billion annually. Additionally, he has led and/or participated in negotiating and structuring numerous transactions, including the raising of over $80 million in venture capital, greater than $500 million in strategic partnerships and licenses, and over $5 billion in M&A transactions.
Currently, Mallon is the acting COO of Polynoma, a development-stage immuno-oncology company, and a Board Director (founder and interim CEO) of a genomics-based precision medicine start-up. Mallon holds a Bachelor’s degree in Medical Technology from The University of Arizona.
Sethuraman “Panch” Panchanathan, Ph.D.
Sethuraman “Panch” Panchanathan is currently the Executive Vice President, ASU Knowledge Enterprise Development, Chief Research and Innovation Officer, as well as the Director for the Center for Cognitive Ubiquitous Computing (CUbiC), and Foundation Chair in Computing and Informatics. He leads the knowledge enterprise development at Arizona State University, which advances research, innovation, strategic partnerships, entrepreneurship, global and economic development at ASU.
Panchanathan was the founding director of the School of Computing and Informatics and was instrumental in founding the Biomedical Informatics Department at ASU. He also served as the chair of the Computer Science and Engineering Department. He founded the Center for Cognitive Ubiquitous Computing (CUbiC) at ASU. CUbiC’s flagship project iCARE, for individuals who are blind and visually impaired, won the Governor’s Innovator of the Year-Academia Award in November 2004.
In 2014, Panchanathan was appointed by President Barack Obama to the U.S. National Science Board (NSB). He has also been appointed by U.S. Secretary of Commerce Penny Pritzker to the National Advisory Council on Innovation and Entrepreneurship (NACIE).
Panchanathan is a Fellow of the National Academy of Inventors (NAI), and a Fellow of the Canadian Academy of Engineering. He is also the Fellow of the Institute of Electrical and Electronics Engineers (IEEE), and the Society of Optical Engineering (SPIE), He is currently serving as the Chair-Elect in the Council on Research (CoR) within the Association of Public and Land-grant Universities (APLU). Panchanathan was the editor-in-chief of the IEEE Multimedia Magazine and is also an editor/associate editor of many other journals and transactions.
His research interests are in the areas of human-centered multimedia computing, haptic user interfaces, person-centered tools and ubiquitous computing technologies for enhancing the quality of life for individuals with disabilities, machine learning for multimedia applications, medical image processing, and media processor designs. Panchanathan has published over 425 papers in refereed journals and conferences and has mentored over 100 graduate students, post-docs, research engineers and research scientists who occupy leading positions in academia and industry. He has been a chair of many conferences, program committee member of numerous conferences, universities and industry.
Panchanathan holds a Ph.D. in electrical and computer engineering from the University of Ottawa in Canada; an M.Tech. in electrical engineering from the Indian Institute of Technology, Madras; a B.E. in electronics and communication engineering from the Indian Institute of Science, Bangalore; and a B.Sc. in physics from the University of Madras in India.
Adelaida Severson, Ph.D.
Dr. Adelaida V. Severson is President and CEO of Bushtex, Inc. In 1994, Dr. Severson founded Bushtex, Inc. with her husband, Barry Severson, as a satellite communications firm specializing in remote broadcast transmissions worldwide. The company, which first began as a side gig in their garage, grew to a full-time requirement, after the pair realized the market need for their services.
Today, Bushtex’s customers range from television networks that need to broadcast sporting and news events from around the world, to corporations wanting to set up teleconferences, to government agencies that need to communicate via satellite. Some notable achievements of Dr. Severson and Bushtex is the coordinating televised NFL Super Bowl Games, the Summer and Winter Olympics since 1990, and supporting our nation’s military outlets with high level surveillance.
Born and raised in Hawaii, Dr. Severson graduated with a B.A. in Journalism and International Relations from the University of Southern California. She received a Masters of Mass Communication and a Ph.D. in Public Administration from Arizona State University. Her background includes public relations, broadcast journalism, marketing, events management, philanthropy, and satellite communications. Additionally, she has traveled to 34 countries, including Vietnam and Cuba and continues to consult on international communications strategies.
Dr. Severson has received numerous awards and accolades with Bushtex throughout her career. Most recently, the AZ Business Magazine named her one of the Most Influential Women in Arizona, Phoenix; Business Journal named her one of 25 Top Dynamic Business Women in Phoenix; in 2013 she was named Gilbert Chamber of Commerce Business Woman of the Year 2013; the AZ Republic called her an “Arizona Original” (a listing of four women who have pioneered the way for women in technology); one of the Most Influential Women in Arizona.
Her community involvement includes serving as an ASU Trustee; former Governing Board of the Gilbert Public School District; Gilbert Chamber of Commerce Board member; National Cronkite Advisory Board; Gilbert Leadership Board (graduated from Class XIII); and a member of the Diocese of Phoenix Bishop’s Stewardship Advisory Council.
R.F. "Rick" Shangraw, Jr., Ph.D.
Rick Shangraw is the chief executive officer of ASU Enterprise Partners and the ASU Foundation for A New American University. Under Shangraw’s leadership, ASU Enterprise Partners was created in 2016 as a new model for diversified revenue generation to support Arizona State University. Enterprise Partners is an umbrella organization for the foundation and affiliate entities that engage in fundraising, applied research, technology transfer, real estate transactions, or collaborative research initiatives that generate support for the university.
Since taking the helm as the foundation’s CEO in 2011, Shangraw has directed a team of more than 150 fundraising professionals that has generated over $700 million in new investments and commitments in support of the university. For five consecutive years (2012–16), the foundation has been awarded the premier, four-star rating from Charity Navigator, the country’s largest and most respected evaluator of nonprofit organizations. The foundation also has received CareerBuilder’s Top Company to Work for in Arizona honors for three consecutive years (2014–16).
Prior to joining the foundation, Shangraw served as ASU’s senior vice president for the Office of Knowledge Enterprise Development (OKED) and director of the Global Institute of Sustainability. As senior vice president for OKED, he was responsible for ASU’s growing annual research portfolio, which placed ASU among the top research institutions in the country without a medical school. As director of the Global Institute of Sustainability, Shangraw oversaw research, education, and problem-solving initiatives, with a special focus on urban environments.
Shangraw serves on the board of several programs and institutes, including the McCain Institute for International Leadership, the Julie Ann Wrigley Global Institute of Sustainability, and The Sustainability Consortium.
Before joining ASU, Shangraw was founder and CEO of Project Performance Corporation, a research and technology consulting firm specializing in environmental, energy, and information management issues. During his tenure, PPC received the Inc. 500 Award for being one of the fastest-growing, privately-held companies in the United States. Prior to PPC, he was on the faculty of Syracuse University.
Shangraw holds a B.A., magna cum laude, in political science and a certificate in environmental studies from Dickinson College; a master of public administration from the Maxwell School at Syracuse University; and a Ph.D. in public administration from the Maxwell School, with a specialization in technology and information policy and organization design.
Shangraw holds professor of practice appointments in the ASU School of Sustainability and the School of Public Affairs in the College of Public Service and Community Solutions.
Special Advisor to the Board:
Michael J. Cleare, Ph.D.
From 2000-2007, Mike was the Executive Director of Science and Technology Ventures at Columbia University. This position included responsibility for all technology transfer activities at Columbia and involved licensing, spin-off/start-up companies, industrial research funding and domestic and international partnerships relating to IP. In August 2007 Mike joined the University of Pennsylvania as Associate Vice Provost for Research, responsible for all technology transfer, IP management and industrial liaison activities. He retired in 2013 having enabled the successful creation of the Penn Centre for Innovation(PCI) covering all knowledge transfer, industrial funding and entrepreneurial activities including incubation of company start-ups based on Penn’s technologies. Mike continues to be involved with PCI as a consultant.
Mike worked for 30 years at Johnson Matthey, a UK-based multinational world leader in advanced materials technology. His experiences range from the Senior R&D Executive through Business Development to a range of senior business management positions, and included service on the main Board of the Company for four years. While in R&D Mike was involved in the discovery and development of a major new class of anti-cancer drugs (platinum based-particularly carboplatin). He served as President of several of the company's major divisions, including Pharmaceutical Materials, Chemicals and Metals, Catalytic Systems and Electronic Materials. He has managed complex global business, negotiated and closed multi-million dollar licensing and technology transfer deals, and entered into multiple research funding agreements with major universities.
For nine years, Dr. Cleare was a member of the board of directors of the Canadian biotechnology company, AnorMed, which he helped to spin off from Johnson Matthey in 1996, until its acquisition by Genzyme in 2006. Mike was a member of the AzTE board of Directors from 2007 until 2016. He is currently a member of board of the UCLA Technology Development Corporation which oversees the promotion of UCLA’s Research, Innovation and Entrepreneurship to benefit society and to create economic value.
Mike holds a B.Sc. and a MS from Imperial College in London and a Ph.D. from London University, where he worked in the laboratories of Nobel Laureate Sir Geoffrey Wilkinson. He has published over forty scientific papers- many in peer reviewed journals, and is a named inventor on over 10 patents including the fundamental composition patent for carboplatin.